Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis

NCT06551519

Active Not RecruitingN/A

Sponsor: Novartis Pharmaceuticals

Conditions: Multiple Sclerosis

Interventions: ofatumumab, DMT category 1

Countries: Germany

This is a prospective, multicenter, observational, non-interventional study (NIS) in patients with Multiple Sclerosis (MS) and routinely assessed serum neurofilament light (sNfL) values in Germany

Eligibility overview

Sex: ALL

Age: 18 Years to 99 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

Participants eligible for inclusion in this study must meet all the following criteria:

1. Written informed consent must be obtained before participation in the study.
2. RMS patients aged 18 or older.
3. Treated in label with EU-approved DMTs for MS category 1 according to current guidelines (Hemmer et al 2023) for at least the last 3 months.
4. Presence of a sNfL test result from a commercially available test not older than 3 months.

Exclusion Criteria:

Participants meeting any of the following criteria are not eligible for inclusion in this study:

1. Patients being treated outside of the approved label of the respective DMT.
2. Simultaneous participation in any interventional study or simultaneous participation in another Novartis-sponsored non-interventional study with ofatumumab.
Locations (89)
  • Albstadt, Baden-Wurttemberg, Germany
  • Hettingen, Baden-Wurttemberg, Germany
  • Mannheim, Baden-Wurttemberg, Germany
  • Schwetzingen, Baden-Wurttemberg, Germany
  • Bamberg, Bavaria, Germany
  • Neuburg A.d. Donau, Bavaria, Germany
  • Regensburg, Bavaria, Germany
  • Unterhaching, Bavaria, Germany
  • Untermeitingen, Bavaria, Germany
  • Weiden in Der Oberpfalz, Bavaria, Germany
  • Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Frankfurt am Main, Hesse, Germany
  • Kassel, Hesse, Germany
  • Quakenbrück, Lower Saxony, Germany
  • Dortmund, North Rhine-Westphalia, Germany
  • Dortmund, North Rhine-Westphalia, Germany
  • Gelsenkirchen, North Rhine-Westphalia, Germany
  • Meerbusch, North Rhine-Westphalia, Germany
  • Siegen, North Rhine-Westphalia, Germany
  • Sundern Sauerland, North Rhine-Westphalia, Germany
  • Chemnitz, Saxony, Germany
  • Dresden, Saxony, Germany
  • Görlitz, Saxony, Germany
  • Leipzig, Saxony, Germany
  • Leipzig, Saxony, Germany
  • Altenburg, Thuringia, Germany
  • Jena, Thuringia, Germany
  • Mühlhausen, Thuringia, Germany
  • Aalen, Germany
  • Altenholz, Germany
  • + 59 more on CT.gov